You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PH 1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Hyperoxaluria Type 1 (PH1) Trial (Nedosiran)

Available
  • Primary Hyperoxaluria Type 1 (PH1)
  • (no location specified)
Aug 7, 2023

GERD Trial in Ljubljana (Linaprazan Glurate 25 mg, Linaprazan Glurate 50 mg, Linaprazan Glurate 75 mg)

Recruiting
  • GERD
  • Linaprazan Glurate 25 mg
  • +2 more
  • Ljubljana, Slovenia
    CRS d.o.o,Ukmarjeva ulica 6
Feb 23, 2023

Stomach Tumor Trial (Trastuzumab deruxtecan, Afatinib)

Not yet recruiting
  • Stomach Neoplasm
  • (no location specified)
Oct 16, 2023

Study of Patients With Primary Hyperoxaluria Type 1 (PH1)

Recruiting
  • Primary Hyperoxaluria Type 1
    • Phoenix, Arizona
    • +10 more
    Aug 11, 2022

    Aged, Older Adults, Healthy Aging Trial in Perth (danceSing Care)

    Completed
    • Aged
    • +3 more
    • danceSing Care
    • Perth, United Kingdom
      Balhousie Care Group
    Sep 24, 2022

    Alzheimer Trial (RB-ADSC)

    Not yet recruiting
    • Alzheimer Disease
    • RB-ADSC
    • (no location specified)
    Dec 19, 2022

    Norovirus Infections Trial in Cypress, New Orleans, Austin (VXA-GI.1.NN, Placebo Tablet)

    Completed
    • Norovirus Infections
    • VXA-GI.1.NN
    • Placebo Tablet
    • Cypress, California
    • +2 more
    Sep 19, 2022

    HIV-1-infection, ART, Cd4+ Lymphocyte Deficiency Trial in Minneapolis (FT538, Vorinostat)

    Not yet recruiting
    • HIV-1-infection
    • +4 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Jan 31, 2023

    PH1, Primary Hyperoxaluria, RNAi Therapeutic Trial in Worldwide (Lumasiran)

    Active, not recruiting
    • PH1
    • +4 more
    • Bordeaux, France
    • +8 more
    Jan 13, 2023

    Bioequivalence Trial in Tempe, Lincoln (efgartigimod PH20 SC as a prefilled syringe presentation, efgartigimod PH20 SC as a vial

    Recruiting
    • Bioequivalence
    • efgartigimod PH20 SC as a prefilled syringe presentation
    • efgartigimod PH20 SC as a vial + syringe presentation
    • Tempe, Arizona
    • +1 more
    Apr 5, 2023

    Phenotyping of the Out-of-proportion Pulmonary Hypertension

    Not yet recruiting
    • 1- Haemodynamic Phenotyping of the Out - of - Proportion PH to Guide Different Therapeutic Lines
    • Right sided heart catheterization
    • Assiut, Egypt
      Mahmoud Badwy
    Sep 18, 2023

    Solid Tumor Trial in United States (STP707)

    Recruiting
    • Solid Tumor
    • Los Angeles, California
    • +3 more
    Jan 27, 2022

    HER2+ Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Trial (SHR-A1811;SHR-1701;capecitabine;oxaliplatin)

    Not yet recruiting
    • HER2+ Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
    • (no location specified)
    Jan 3, 2023

    CML (Chronic Myelogenous Leukemia Trial (KDS-1001)

    Not yet recruiting
    • CML (Chronic Myelogenous Leukemia
    • (no location specified)
    Jul 27, 2022

    Primary Hyperoxaluria Type 1 (PH1), Primary Hyperoxaluria Type 2 (PH2), Kidney Diseases Trial in Worldwide (DCR-PHXC)

    Enrolling by invitation
    • Primary Hyperoxaluria Type 1 (PH1)
    • +5 more
    • San Francisco, California
    • +19 more
    Jun 22, 2022

    Solid Tumor Malignancy Trial in Hackensack (Selinexor, Irinotecan)

    Withdrawn
    • Solid Tumor Malignancy
    • Hackensack, New Jersey
      John Theurer Cancer Center at HackensackUMC
    Dec 14, 2021

    AML, MDS, ALL, Adult Trial in Hackensack, New York (SOC + TSC-100, SOC + TSC-101, Control)

    Recruiting
    • AML
    • +2 more
    • SOC + TSC-100
    • +2 more
    • Hackensack, New Jersey
    • +1 more
    Aug 11, 2022

    Phosphorus Metabolism Disorders, Acid-Base Balance Disorder Trial in Warsaw (Group 1: B) Dbic 35 -30 mmol/L C) Dbic 30- 35

    Completed
    • Phosphorus Metabolism Disorders
    • Acid-Base Balance Disorder
    • Group 1: B) Dbic 35 -30 mmol/L C) Dbic 30- 35 mmol/L
    • Group 2: C) Dbic 30 -35 mmol/L B) Dbic 35- 30 mmol/L
    • Warsaw, Poland
      Wieliczko Monika
    May 21, 2023

    Heart Failure, Pulmonary Hypertension Trial in Vancouver, Ottawa (Rivet Shunt)

    Not yet recruiting
    • Heart Failure
    • Pulmonary Hypertension
    • Rivet Shunt
    • Vancouver, British Columbia, Canada
    • +1 more
    Sep 26, 2022

    Healthy Participants Trial (BMS-986465, Placebo, Pegasys)

    Not yet recruiting
    • Healthy Participants
    • (no location specified)
    Nov 17, 2023

    Hypertension, Pulmonary Trial in Germany, United Kingdom (Blood Sample, Cardiac MRI)

    Completed
    • Hypertension, Pulmonary
    • Blood Sample
    • Cardiac MRI
    • Bonn, Germany
    • +7 more
    Aug 16, 2022

    Malignant Tumors, Metastatic Cancer Trial in Shanghai, Tianjin, Hangzhou (BPI-421286)

    Recruiting
    • Malignant Neoplasms
    • Metastatic Cancer
    • Shanghai, Shanghai, China
    • +4 more
    Apr 5, 2022

    Adhesive Dental Trial in London (Tetranite Implant Stabilization Material)

    Not yet recruiting
    • Adhesive Dental
    • Tetranite Implant Stabilization Material
    • London, United Kingdom
      Norton Implants
    Sep 9, 2022

    Idiopathic Pulmonary Fibrosis Trial in Belfast (Caveolin-1-Scaffolding-Protein-Derived Peptide (LTI-03), Placebo)

    Completed
    • Idiopathic Pulmonary Fibrosis
    • Caveolin-1-Scaffolding-Protein-Derived Peptide (LTI-03)
    • Placebo
    • Belfast, United Kingdom
      Celerion
    Mar 4, 2022

    Solid Tumor, Non Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Rochester (VSV-IFNß-NIS, Pembrolizumab)

    Recruiting
    • Solid Tumor
    • +2 more
    • VSV-IFNβ-NIS
    • Pembrolizumab
    • Rochester, Minnesota
      Mayo Clinic
    Sep 26, 2022